Reading pathogen epigenomes; a new stem cell; dealing with research misconduct; monkey fossils; exploratory mice grow new neurons; watching metamorphosis
The Scientist
Most Recent
By reprogramming human fibroblasts into pluripotent stem cells with somatic cell nuclear transfer, scientists have come up with a viable alternative to iPSCs.
Researchers track DNA modifications and gene expression in stem cells as they differentiate.
Some of the 200 or so human embryonic stem cell lines approved for federal funding may have been derived from sperm or eggs of unconsenting donors.
BioTime finalizes a deal to buy Geron’s defunct human embryonic stem cell assets.
The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
Scientists fighting the federal funding of human embryonic stem cell research bring their case before the country’s highest court.
John B. Gurdon and Shinya Yamanaka jointly take home this year’s Nobel Prize in Medicine for turning back the developmental clock.
Republicans unveil their quadrennial list of policy positions, and it toes the party line on some science issues while upping support for others.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
